Additional Information

Description

Metoprolol tartrate 25 mg is a selective beta-1 adrenergic receptor blocker used for the management of hypertension, angina pectoris, and certain cardiac arrhythmias. It reduces myocardial oxygen demand by decreasing heart rate, cardiac output, and blood pressure. This action helps in lowering blood pressure and improving cardiac efficiency, making it effective in preventing heart-related complications such as strokes and heart attacks.

The medication is supplied in 25 mg oral tablets, with a standard dosage regimen based on the patient's condition and response to treatment. It is commonly administered in divided doses due to its short half-life. Metoprolol tartrate is absorbed rapidly, reaching peak plasma concentration within one to two hours after oral administration.

Common adverse effects include dizziness, fatigue, bradycardia, hypotension, and gastrointestinal discomfort. In rare cases, it may cause bronchospasm, worsening of heart failure, or severe hypotension. Patients with asthma, bradycardia, or advanced heart block require caution when using this medication.